Jundishapur Journal of Microbiology

Published by: Kowsar

Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus

Auttawit Sirichoat 1 , Sujintana Wongthong 1 , Ratdawan Kanyota 1 , Ratree Tavichakorntrakool 2 , Aroonwadee Chanawong 2 , Jariya Umka Welbat 3 and Aroonlug Lulitanond 2 , *
Authors Information
1 Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
2 Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand
3 Department of Anatomy, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
Article information
  • Jundishapur Journal of Microbiology: January 01, 2016, 9 (1); e26069
  • Published Online: January 2, 2016
  • Article Type: Research Article
  • Received: December 13, 2014
  • Revised: October 5, 2015
  • Accepted: October 16, 2015
  • DOI: 10.5812/jjm.26069

To Cite: Sirichoat A, Wongthong S, Kanyota R, Tavichakorntrakool R, Chanawong A, et al. Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus, Jundishapur J Microbiol. 2016 ; 9(1):e26069. doi: 10.5812/jjm.26069.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23(1): 99-139[DOI][PubMed]
  • 2. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350(9092): 1670-3[DOI][PubMed]
  • 3. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40(1): 135-6[PubMed]
  • 4. Holmes NE, Johnson PD, Howden BP. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J Clin Microbiol. 2012; 50(8): 2548-52[DOI][PubMed]
  • 5. Performance standards for antimicrobial susceptibility testing: Twenty-second informational supplement M100-S16. 2012;
  • 6. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis. 2001; 7(2): 327-32[DOI][PubMed]
  • 7. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother. 2001; 47(4): 399-403[PubMed]
  • 8. Sieradzki K, Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol. 1999; 181(24): 7566-70[PubMed]
  • 9. Moreira B, Boyle-Vavra S, deJonge BL, Daum RS. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1997; 41(8): 1788-93[PubMed]
  • 10. Sieradzki K, Tomasz A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol. 2003; 185(24): 7103-10[PubMed]
  • 11. Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus. BMC Infect Dis. 2011; 11: 287[DOI][PubMed]
  • 12. Sakoulas G, Eliopoulos GM, Moellering RC, Novick RP, Venkataraman L, Wennersten C, et al. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis. 2003; 187(6): 929-38[DOI][PubMed]
  • 13. Nelson JL, Rice KC, Slater SR, Fox PM, Archer GL, Bayles KW, et al. Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis. Antimicrob Agents Chemother. 2007; 51(2): 616-22[DOI][PubMed]
  • 14. Kondo Y, Ito T, Ma XX, Watanabe S, Kreiswirth BN, Etienne J, et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother. 2007; 51(1): 264-74[DOI][PubMed]
  • 15. Alsunaien T, Pratten J, Ng YL, Gulabivala K, Ready D. Effect of Transport and Storage Conditions on Recovery of Root Canal Isolates. Int Endod J. 2010; 43(4): 353
  • 16. Pfeltz RF, Singh VK, Schmidt JL, Batten MA, Baranyk CS, Nadakavukaren MJ, et al. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob Agents Chemother. 2000; 44(2): 294-303[PubMed]
  • 17. Sasaki T, Tsubakishita S, Tanaka Y, Sakusabe A, Ohtsuka M, Hirotaki S, et al. Multiplex-PCR method for species identification of coagulase-positive staphylococci. J Clin Microbiol. 2010; 48(3): 765-9[DOI][PubMed]
  • 18. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol. 2003; 69(1): 18-23[PubMed]
  • 19. Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J Bacteriol. 2007; 189(6): 2553-7[DOI][PubMed]
  • 20. Tsompanidou E, Sibbald MJ, Chlebowicz MA, Dreisbach A, Back JW, van Dijl JM, et al. Requirement of the agr locus for colony spreading of Staphylococcus aureus. J Bacteriol. 2011; 193(5): 1267-72[DOI][PubMed]
  • 21. Hamilton-Miller JM, Gargan RA. Rapid screening for urease inhibitors. Invest Urol. 1979; 16(5): 327-8[PubMed]
  • 22. Han JH, Edelstein PH, Lautenbach E. Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2012; 67(10): 2346-9[DOI][PubMed]
  • 23. Liu C, Chen ZJ, Sun Z, Feng X, Zou M, Cao W, et al. Molecular characteristics and virulence factors in methicillin-susceptible, resistant, and heterogeneous vancomycin-intermediate Staphylococcus aureus from central-southern China. J Microbiol Immunol Infect. 2015; 48(5): 490-6[DOI][PubMed]
  • 24. Jang HC, Kang SJ, Choi SM, Park KH, Shin JH, Choy HE, et al. Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III. PLoS One. 2012; 7(11)[DOI][PubMed]
  • 25. Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China. PLoS One. 2013; 8(9)[DOI][PubMed]
  • 26. Ueda T, Kaito C, Omae Y, Sekimizu K. Sugar-responsive gene expression and the agr system are required for colony spreading in Staphylococcus aureus. Microb Pathog. 2011; 51(3): 178-85[DOI][PubMed]
  • 27. Park C, Shin NY, Byun JH, Shin HH, Kwon EY, Choi SM, et al. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation. J Med Microbiol. 2012; 61: 345-52[DOI][PubMed]
  • 28. Dai Y, Zhou X, Ma X, Lu H, Li H. Misidentification of vancomycin-resistant Staphylococcus aureus as coagulase-negative Staphylococcus. J Med Microbiol. 2012; 61: 1454-8[DOI][PubMed]
  • 29. Derakhshan S, Sattari M, Bigdeli M. Effect of subinhibitory concentrations of cumin (Cuminum cyminum L.) seed essential oil and alcoholic extract on the morphology, capsule expression and urease activity of Klebsiella pneumoniae. Int J Antimicrob Agents. 2008; 32(5): 432-6[DOI][PubMed]
  • 30. Fong RK, Low J, Koh TH, Kurup A. Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore. Eur J Clin Microbiol Infect Dis. 2009; 28(8): 983-7[DOI][PubMed]
  • 31. Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2006; 50(2): 428-38[DOI][PubMed]
  • 32. Ruef C. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. Infection. 2004; 32(6): 315-27[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments